Navigation Links
CoreLab Partners Opens Office in Tokyo, Japan
Date:1/17/2012

PRINCETON, N.J., Jan. 17, 2012 /PRNewswire/ -- Signaling a further commitment to expand its business model in the Pacific Rim and building a global presence as one of the largest imaging and cardiac safety core labs in the world, CoreLab Partners, Inc. today has announced the opening of an office in Tokyo, Japan under the wholly owned subsidiary of CoreLab Partners Japan, K.K.

"We are pleased to announce the creation of our new subsidiary in Asia corresponding with the opening of an office in central Tokyo," said CoreLab Partners' President and Chief Executive Officer, Dr. Mike Woehler. "This expanded presence is a natural extension of our geographic reach and global strategy to serve our growing base of multinational biopharma companies operating in the region and will complement our operational capability, which was established in Shanghai, China, over a decade ago," added Woehler.

CoreLab Partners currently has a strong business alliance in Japan with Suzuken Co. Ltd., which markets its cardiac safety services; this new presence is designed to further establish the global brand in the Pacific Rim and expand their full line of imaging sciences capabilities in Southeast Asia. "CoreLabs has been present in the region since 1999 and has conducted hundreds of drug development studies in both cardiac safety and imaging for a variety of sponsor partners. The addition of a local Regional Director and Business Development professional will allow CoreLab Partners to better service our client base by nurturing current relationships and opening up new markets for our full line of cardiac safety and imaging services," said Kevin Duffy, Vice President, Global Business Development.

About CoreLab Partners, Inc.

CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with board certified, sub-specialty trained Radiologists, Cardiologists, nuclear medicine physicians and Oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, emerging technologies and service quality, CoreLabs is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of automated ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring and Pulse Wave Analysis.

Contact:
Kevin D. Duffy
Vice President, Global Business Development
Email: kduffy@corelabpartners.com
Phone: 609-936-2600

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CoreLab Partners, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CoreLab Partners Completes First TQT Study in Japan
2. CoreLab Partners Launches New DXA Imaging Service Offerings
3. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
4. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
5. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
6. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
7. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
8. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
9. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
10. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
11. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... April 27, 2017  Pendant Biosciences, Inc. (formerly Nanoferix, ... modification and drug delivery technologies, today announced that it ... @ Toronto . ... Pendant Biosciences, noted, "We are excited to become part ... community, and are honored to be the first ...
(Date:4/26/2017)... SAN DIEGO, CALIF. (PRWEB) , ... April 26, ... ... Mother’s Day? Lajollacooks4u, San Diego’s premiere team-building and cooking events company, offers ... cooking classes. , Menus specialize in California cuisine, and guests leave inspired ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... GMP expectations for phase I clinical trials comes to Tampa, San Francisco and ... and pharma professionals representing FDA regulated organizations such as Pfizer Inc., Teva Pharmaceuticals, ...
(Date:4/26/2017)... ... April 26, 2017 , ... Baltimore ... Bioflash MailGuardtm mail security screening solution at the National Postal Forum 2017 in ... provides a fast, highly accurate, easy to use and low cost threat detection ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
Breaking Biology News(10 mins):